Search Results

search

Search Filters

Tag
Gene Therapy
Lexeo_Logo.png
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
March 24, 2025 07:00 ET | Lexeo Therapeutics
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
March 20, 2025 16:05 ET | Vor Biopharma
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment...
Ori-Iro-LBIC-Shoot-Sept_0029
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
March 18, 2025 09:00 ET | Oribiotech Ltd
Oribiotech Ltd. (Ori), announced the launch of its Preferred Partner Network (PPN), bringing together top AMCs and CDMOs.
ocugen_4C_LOGO (002).png
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
March 18, 2025 08:02 ET | Ocugen
OCU200 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reportedDosing of the second cohort has been approved MALVERN, Pa., March 18,...
purespring logo.png
Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer
March 12, 2025 03:00 ET | Purespring Therapeutics
Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis Europe and will lead the Company as it advances pioneering kidney disease...
Gene Therapy Market
Gene Therapy Market Global Forecast to 2032: Biopharma Giants Lead Gene Therapy Market Expansion – Latest Developments & Projections
March 07, 2025 04:09 ET | Research and Markets
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene Silencing), Vector (Viral (Retroviral, AAV), Non-Viral (Oligonucleotide)), Gene Type (Receptors, Cytokine),...
22157.jpg
Gene Therapy Collaboration and Licensing Agreements Trends Report and Directory 2024: Comprehensive Access to 770 Deals Announced Since 2016 - Upfront, Milestone, Royalties Terms
March 06, 2025 11:05 ET | Research and Markets
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Logo.png
Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight
March 05, 2025 13:00 ET | DelveInsight Business Research LLP
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and...
Siren Bio Logo with Name.png
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
March 05, 2025 12:15 ET | Siren Biotechnology, Inc.
Siren Biotechnology expands Clinical and Scientific Advisory Board with key industry leaders
ocugen_4C_LOGO (002).png
Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
March 05, 2025 07:02 ET | Ocugen
Reached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical development by two to three yearsCompleted dosing in...